August 7th 2025
🫀 Can we treat certain heart conditions without opening the chest? At Cardiawave, we believe the answer is yes.
During the 100% HealthTech live broadcast hosted by France Biotech, our CEO Carine Schorochoff was invited to speak on the program Parole d’entrepreneur, moderated by Fabrice Lundy.
Carine presented Cardiawave’s mission and the results of our non-invasive ultrasound therapy on 100 patients who suffer from severe symptomatic aortic valve stenosis, a serious condition affecting over 1.3 million people in Europe (source: ESCardio).
This innovative technology aims to provide a safe and effective therapeutic approach for patients who are not eligible for aortic valve replacement or refusing such interventions.
🎙️ Watch the full interview (in French) to learn more about our technology and vision:
https://www.linkedin.com/feed/update/urn:li:activity:7355527782950400002/?actorCompanyId=26415925
[Valvosoft® is a medical device exclusively intended for clinical investigations (not CE marked or approved for marketing).]
#Cardiawave #HealthTech #MedTech #Innovation #AorticStenosis #UltrasoundTherapy #NonInvasive #FranceBiotech #FrenchTech #NIUT
#HEGP, @AP-HP, Assistance Publique – Hôpitaux de Paris @Physics for Medicine Paris, #InstitutLangevin, @CNRS, @ESPCI Paris – PSL, @Inserm @RHU_STOP_AS
#FrenchCare #Health20 @france-biotech @medicen-paris-region @bpi-france @focusedultrasoundfoundation @eic-scalingclub
